CAS: 346692-04-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-(4-butylphenyl)-4-fluorobenzenesulfonamide REF: IN-DA00CNHBCAS: 346692-04-4 | 98% | 118.00 €~658.00 € | Fri 15 Nov 24 |
 | DC260126 REF: TM-T7127CAS: 346692-04-4 | 99.77% | 35.00 €~273.00 € | Fri 22 Nov 24 |
 | DC260126 REF: 3D-WNA69204CAS: 346692-04-4 | Min. 95% | To inquire | Fri 27 Dec 24 |
N-(4-butylphenyl)-4-fluorobenzenesulfonamide
CAS:346692-04-4
Formula:
C16H18FNO2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
307.3830
Ref: IN-DA00CNHB
| 5mg | 118.00 € | ||
| 25mg | 145.00 € | ||
| 100mg | 160.00 € | ||
| 250mg | 269.00 € |
Estimated delivery in United States, on Friday 15 Nov 2024
DC260126
CAS:346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40)
Formula:
C16H18FNO2S
Purity:
99.77%
Color and Shape:
Solid
Molecular weight:
307.38
Ref: TM-T7127
| 5mg | 35.00 € | ||
| 10mg | 46.00 € | ||
| 25mg | 91.00 € | ||
| 50mg | 129.00 € | ||
| 100mg | 180.00 € | ||
| 200mg | 273.00 € | ||
| 1mL*10mM (DMSO) | 37.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
DC260126
CAS:346692-04-4
DC260126 is an investigational drug for the treatment of human breast cancer. DC260126 is a …
Formula:
C16H18FNO2S
Purity:
Min. 95%
Molecular weight:
307.38 g/mol
Ref: 3D-WNA69204
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
